Posted by: DrugsNews on: 31 Jul, 2010
Accutane Still Marketed in U.S. by Illegal Online Venders Despite the fact that Accutane was pulled from the U.S. market in 2009, online venders continue to sell drugs marketed under the name of the popular acne medication. The struggle to cap the illegal online distribution of the medication illustrates just one of many facets in [...]
Posted by: DrugsNews on: 31 Jul, 2010
Evamist Estrogen Spray May Pose Health Risk to Children and Pets, FDA Warns According to a recent safety alert posted by the Food and Drug Administration (FDA) this week, topical hormone spray Evamist, used in the treatment of menopausal hot flashes, is currently under investigation for possible safety risks associated with unintended exposure to children [...]
Posted by: DrugsNews on: 31 Jul, 2010
Drop Mouth-to-mouth When Doing CPR, Say Experts Bystanders should focus on “hands only” chest compressions during CPR (a life saving procedure) and not bother with the mouth-to-mouth bit, says a leading expert who quoted two new studies from the USA and Europe. (CPR stands for cardiopulmonary resuscitation) You can read an editorial accompanying the study [...]
Posted by: DrugsNews on: 31 Jul, 2010
Thirty Million Women Will Gain From Health Reform Law, Including About 15 Million Uninsured Approximately thirty million American women will gain from the new health reform law over the next ten years, according to a new report from The Commonwealth Fund, a private foundation based in New York. The authors state that the law will [...]
Posted by: DrugsNews on: 31 Jul, 2010
Seven Influenza Vaccines For Coming Season Approved By FDA The US FDA (Food and Drug Administration) has approved vaccines for the 2010-2011 USA influenza season, protecting against three strains of influenza, including the H1N1 virus which caused the 2009 pandemic. In 2009, because the H1N1 virus appeared after seasonal vaccine production commenced, two separate vaccines [...]
Posted by: DrugsNews on: 31 Jul, 2010
Why Are UK Stroke Patients Still Not Getting Prompt Treatment? The Lancet this week featured an Editorial discussing a recent report from the UK Vascular Society and Royal College of Physicians showing that the waiting time for vascular surgery after symptoms of stroke or transient ischemic attack is far too long. Guidelines set by the [...]
Posted by: DrugsNews on: 31 Jul, 2010
FDA Approves Embryonic Stem Cell-Based Therapy For Patients With Acute Spinal Cord Injury The US FDA (Food and Drug Administration) has lifted a clinical hold on Geron’s Investigational New Drug (IND) application – the Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may now go ahead. GRNOPC1 is the first [...]
Posted by: DrugsNews on: 31 Jul, 2010
Endo Pharma Q2 Revenues Up 6% Endo Pharmaceuticals, a US-based, specialty healthcare solutions company, focused on branded products and specialty generics, has reported revenues of $396.5m for the second quarter ended June 30, 2010, an increase of 6%, compared to $373.1m for the comparable period in 2009. Read more about Endo Pharma Q2 Revenues Up [...]
Posted by: DrugsNews on: 31 Jul, 2010
Astrazeneca Q2 Revenues Increase To $8.18bn Astrazeneca, a global biopharmaceutical company that discovers, develops, manufactures and markets prescription medicines, has reported revenues of $8.18bn for the second quarter ended June 30, 2010, compared to $7.96bn for the comparable period in 2009. Read more about Astrazeneca Q2 Revenues Increase To $8.18bn No tags for this post.
Posted by: DrugsNews on: 31 Jul, 2010
N.J. gov: Rutgers ‘disjointed’ on medical marijuana TRENTON, N.J. – Gov. Chris Christie said Friday he was surprised that Rutgers University turned down an opportunity to be the lone grower of the state’s medical marijuana crop because it was the school’s idea. Read more about N.J. gov: Rutgers ‘disjointed’ on medical marijuana No tags for [...]